Early experience outcome of a reinforced Bioscaffold in inguinal hernia repair: A case series

No patients reported any postoperative pain that was disabling or lasted beyond three months. No patients required a narcotic pain medications refill. RBS represent a novel hernia mesh that may minimize the inflammatory response seen in synthetic hernia mesh patients and thus may lead to less postoperative pain. To confirm these results, as well as evaluate the effect of RBS on late-onset CPIP, a larger prospective series should be studied with longer follow-up.